BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34790729)

  • 1. An integrated model of
    Zhang K; Han Z; Zhao H; Liu S; Zeng F
    Ann Transl Med; 2021 Oct; 9(20):1523. PubMed ID: 34790729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
    Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X
    Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development and validation of a m6A-lncRNAs based prognostic model for overall survival in lung squamous cell carcinoma.
    Huang H; Wu W; Lu Y; Pan X
    J Thorac Dis; 2022 Oct; 14(10):4055-4072. PubMed ID: 36389308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma.
    Weng C; Wang L; Liu G; Guan M; Lu L
    Front Oncol; 2021; 11():763027. PubMed ID: 34868980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a prognostic model for lung squamous cell carcinoma based on seven N6-methylandenosine-related autophagy genes.
    Yu X; Liu J; Xie R; Chang M; Xu B; Zhu Y; Xie Y; Yang S
    Math Biosci Eng; 2021 Aug; 18(5):6709-6723. PubMed ID: 34517553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prognostic 11-DNA methylation signature for lung squamous cell carcinoma.
    Zhang J; Luo L; Dong J; Liu M; Zhai D; Huang D; Ling L; Jia X; Luo K; Zheng G
    J Thorac Dis; 2020 May; 12(5):2569-2582. PubMed ID: 32642165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival-associated N
    Qu J; Wang L; Jiang M; Wei Z; Fu G; Zhang X
    BMC Cancer; 2021 Nov; 21(1):1265. PubMed ID: 34814861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
    Qi LW; Jia JH; Jiang CH; Hu JM
    Front Genet; 2020; 11():614566. PubMed ID: 33519919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes.
    Jia E; Ren N; Guo B; Cui Z; Zhang B; Xue J
    World J Surg Oncol; 2022 Feb; 20(1):59. PubMed ID: 35220962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
    Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
    Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
    Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
    Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma.
    Chen Y; Jiang X; Li X; Yan D; Liu J; Yang J; Yan S
    Ann Transl Med; 2021 Aug; 9(16):1346. PubMed ID: 34532483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of pathology-specific regulators of m
    Li N; Zhan X
    EPMA J; 2020 Sep; 11(3):485-504. PubMed ID: 32849929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
    Xu F; Zhang H; Chen J; Lin L; Chen Y
    Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of the Prognostic Role and Mutational Characteristics of m6A-Related Genes in Lung Squamous Cell Carcinoma.
    Gu C; Shi X; Qiu W; Huang Z; Yu Y; Shen F; Chen Y; Pan X
    Front Cell Dev Biol; 2021; 9():661792. PubMed ID: 33842487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m
    Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
    Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
    Deng M; Fang L; Li SH; Zhao RC; Mei J; Zou JW; Wei W; Guo RP
    Mutagenesis; 2021 Oct; 36(5):369-379. PubMed ID: 34467992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Immune Cell Infiltration of m6a-Related lncRNA in Lung Squamous Cell Carcinoma and Construction of Relevant Prognostic Models.
    Zhang P; Li H; Cheng X; Wang W
    Biomed Res Int; 2022; 2022():9139823. PubMed ID: 35872842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma.
    Wang Y; Zhao X; Li J; Wang X; Hu W; Zhang X
    Technol Cancer Res Treat; 2022; 21():15330338221085373. PubMed ID: 35343834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.